EXHIBIT 1
JOINT FILING AGREEMENT
The undersigned parties hereby agree that this Amendment No. 1 to the Statement of Beneficial Ownership on Schedule 13G filed herewith by the undersigned parties, relating to the common stock, par value $0.0001 per share of TScan Therapeutics, Inc., is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, on behalf of each such person.
PITANGO HEALTHTECH FUND I, L.P. | |
| |
By: Pitango H.T. Fund I, L.P., its General Partner | |
By: Pitango GP Health Holdings Ltd., its general partner | |
| |
By: | /s/ Eyal Klein | |
Name: Eyal Klein | |
Title: Chief Financial Officer | |
| |
By: | /s/ Ittai Harel | |
Name: Ittai Harel | |
Title: Managing Director | |
| |
Date: February 8, 2024 | |
PITANGO HEALTHTECH FUND I - ISRAEL L.P. | |
| |
By: Pitango H.T. Fund I, L.P., its General Partner | |
By: Pitango GP Health Holdings Ltd., its general partner | |
| |
By: | /s/ Eyal Klein | |
Name: Eyal Klein | |
Title: Chief Financial Officer | |
| |
By: | /s/ Ittai Harel | |
Name: Ittai Harel | |
Title: Managing Director | |
| |
Date: February 8, 2024 | |
PITANGO HEALTHTECH PRINCIPALS FUND I, L.P. | |
| |
By: Pitango H.T. Fund I, L.P., its General Partner | |
By: Pitango GP Health Holdings Ltd., its general partner | |
| |
By: | /s/ Eyal Klein | |
Name: Eyal Klein | |
Title: Chief Financial Officer | |
| |
By: | /s/ Ittai Harel | |
Name: Ittai Harel | |
Title: Managing Director | |
| |
Date: February 8, 2024 | |
PITANGO H.T. FUND I, L.P. | |
| |
By: Pitango GP Health Holdings Ltd., its general partner | |
| |
By: | /s/ Eyal Klein | |
Name: Eyal Klein | |
Title: Chief Financial Officer | |
| |
By: | /s/ Ittai Harel | |
Name: Ittai Harel | |
Title: Managing Director | |
| |
Date: February 8, 2024 | |